TOREKOV, Sweden--(BUSINESS WIRE)--
Regulatory News:
Nolato (STO:NOLAB) has completed its acquisition of Swiss company Treff AG. The final purchase price for the company is SEK 418 million. Treff’s sales for 2016 are estimated at just over SEK 450 million, with an EBITDA margin of around 11.5%. The EBITDA multiple is approximately 7.5 – 8.0 times.
The company will be consolidated from 3 October. Around two-thirds of Nolato Treff’s operations will be reported within Nolato Industrial, and one-third within Nolato Medical. The acquisition is expected to have a marginal positive effect on Nolato’s earnings per share for the current year.
The transaction will be financed using existing credit agreements. Nolato will continue to enjoy a strong financial position following the acquisition.
---------
Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Mid Cap segment, where they are included in the Industrials sector.
This information is information that Nolato AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 4.00 pm CET on 3 October, 2016.
This information was brought to you by Cision http://news.cision.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161003006032/en/
